Ambit
Ambit operates a tech-enabled healthcare services company that focuses on rare diseases. Its data and analytics reduce the time to diagnosis and its platform helps the pain points associated with rare diseases as it also helps biopharma companies to develop treatments for patients with rare and specialty diseases. The company was founded in 2021.
Ambit
Ambit operates a tech-enabled healthcare services company that focuses on rare diseases. Its data and analytics reduce the time to diagnosis and its platform helps the pain points associated with rare diseases as it also helps biopharma companies to develop treatments for patients with rare and specialty diseases. The company was founded in 2021.
TL;DR
What they do: Tech-enabled patient support platform focused on reducing time to diagnosis for rare/genetic diseases
Founded: 2021
Services: Free 1:1 virtual support, connections to genetic counseling and testing, educational resources
Headcount (approx.): 117 employees
Known funding (public): Seed stage; total disclosed funding listed as $2,930,000 (USD) with last funding date 2023-09-29
Company Overview
Problem Domain
Rare and specialty genetic diseases; diagnostic delay and patient support
Founded
2021
Industry
Healthcare; Patient support for rare/genetic diseases
Funding Track Record
2930000.00 USD
Public profiles indicate a Seed round; specific investor names are not published in the provided evidence.